Alfuzosin for Treating Acute Urinary Retention

Summary

The primary objective of the study is to assess the efficacy of alfuzosin 10mg daily in the return to successful voiding after removal of the catheter following a first episode of acute urinary retention (AUR) in patients suffering from benign prostatic hyperplasia (BPH).

Timeline

Start

2006-02

Primary completion

2007-04

Completion

—

Drugs

Indications